loadpatents
Patent applications and USPTO patent grants for Pang; Roy H.L..The latest application filed is for "provasopressin antagonists and uses thereof".
Patent | Date |
---|---|
Provasopressin Antagonists And Uses Thereof App 20220242947 - North; William G. ;   et al. | 2022-08-04 |
Antagonists for abdominal vasopressin V2 receptor and uses thereof Grant 10,407,504 - North , et al. Sept | 2019-09-10 |
Provasopressin antagonists and uses thereof Grant 10,155,810 - North , et al. Dec | 2018-12-18 |
Provasopressin Antagonists And Uses Thereof App 20170107283 - North; William G. ;   et al. | 2017-04-20 |
Antagonists For Abdominal Vasopressin V2 Receptor And Uses Thereof App 20170107292 - North; William G. ;   et al. | 2017-04-20 |
Antagonists For Abdominal Vasopressin V2 Receptor And Uses Thereof App 20140341810 - North; William G. ;   et al. | 2014-11-20 |
Provasopressin Antagonists And Uses Thereof App 20140341802 - North; William G. ;   et al. | 2014-11-20 |
Morphogen-induced nerve regeneration and repair Grant 7,557,078 - Rueger , et al. July 7, 2 | 2009-07-07 |
Osteogenic Proteins App 20080233170 - Oppermann; Hermann ;   et al. | 2008-09-25 |
Osteogenic proteins App 20070166353 - Oppermann; Hermann ;   et al. | 2007-07-19 |
Protein-induced morphogenesis of kidney tissue Grant 7,196,056 - Cohen , et al. March 27, 2 | 2007-03-27 |
Osteogenic proteins Grant 7,176,284 - Oppermann , et al. February 13, 2 | 2007-02-13 |
Porous particulate collagen sponges App 20060135921 - Wiercinski; Robert A. ;   et al. | 2006-06-22 |
Morphogen treatments for limiting proliferation of epithelial cells Grant 7,060,680 - Cohen , et al. June 13, 2 | 2006-06-13 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases Grant 7,056,882 - Kuberasampath , et al. June 6, 2 | 2006-06-06 |
Osteogenic Devices App 20060116507 - OPPERMANN; HERMANN ;   et al. | 2006-06-01 |
Osteogenic devices App 20050255141 - Oppermann, Hermann ;   et al. | 2005-11-17 |
Osteogenic devices Grant 6,919,308 - Oppermann , et al. July 19, 2 | 2005-07-19 |
Tissue composites and uses thereof App 20050129730 - Pang, Roy H.L. ;   et al. | 2005-06-16 |
Morphogen-induced modulation of inflammatory response App 20050096339 - Kuberasampath, Thangavel ;   et al. | 2005-05-05 |
Methods and compositions for the treatment of motor neuron injury and neuropathy App 20050065083 - Rueger, David C. ;   et al. | 2005-03-24 |
Morphogen-induced neural cell adhesion Grant 6,800,603 - Rueger , et al. October 5, 2 | 2004-10-05 |
Protein-induced morphogenesis App 20040102373 - Cohen, Charles M. ;   et al. | 2004-05-27 |
Osteogenic proteins App 20040077546 - Oppermann, Hermann ;   et al. | 2004-04-22 |
Methods and compositions for the treatment of motor neuron injury and neuropathy Grant 6,723,698 - Rueger , et al. April 20, 2 | 2004-04-20 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases App 20030224979 - Kuberasampath, Thangavel ;   et al. | 2003-12-04 |
Osteogenic devices App 20030224996 - Opperman, Hermann ;   et al. | 2003-12-04 |
Morphogen treatments for limiting proliferation of epithelial cells App 20030125230 - Cohen, Charles M. ;   et al. | 2003-07-03 |
Method of using recombinant osteogenic protein to repair bone or cartilage defects Grant 6,586,388 - Oppermann , et al. July 1, 2 | 2003-07-01 |
Morphogen-induced Nerve Regeneration And Repair App 20030104993 - RUEGER, DAVID C. ;   et al. | 2003-06-05 |
Osteogenic devices Grant 6,551,995 - Oppermann , et al. April 22, 2 | 2003-04-22 |
Osteogenic Devices App 20030069401 - OPPERMANN, HERMANN ;   et al. | 2003-04-10 |
Methods And Compositions For The Treatment Of Motor Neuron Injury And Neuropathy App 20020049159 - RUEGER, DAVID C. ;   et al. | 2002-04-25 |
60A protein-induced morphogenesis Grant 6,211,146 - Kuberasampath , et al. April 3, 2 | 2001-04-03 |
Morphogen-enriched dietary composition Grant 6,022,853 - Kuberasampath , et al. February 8, 2 | 2000-02-08 |
Morphogen treatment of gastrointestinal ulcers Grant 5,972,884 - Cohen , et al. October 26, 1 | 1999-10-26 |
Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith Grant 5,958,441 - Oppermann , et al. September 28, 1 | 1999-09-28 |
Morphogen-induced liver regeneration Grant 5,849,686 - Kuberasampath , et al. December 15, 1 | 1998-12-15 |
Morphogen treatment of gastrointestinal ulcers Grant 5,739,107 - Cohen , et al. April 14, 1 | 1998-04-14 |
Method of selectively extracting osteogenic protein Grant 5,714,589 - Oppermann , et al. February 3, 1 | 1998-02-03 |
Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases Grant 5,674,844 - Kuberasampath , et al. October 7, 1 | 1997-10-07 |
Morphogen induced periodontal tissue regeneration Grant 5,656,593 - Kuberasampath , et al. August 12, 1 | 1997-08-12 |
OP-3-induced morphogenesis Grant 5,652,337 - Oppermann , et al. July 29, 1 | 1997-07-29 |
Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists Grant 5,418,135 - Pang May 23, 1 | 1995-05-23 |
Synthetic bioadhesive Grant 5,374,431 - Pang , et al. December 20, 1 | 1994-12-20 |
Osteogenic devices Grant 5,354,557 - Oppermann , et al. * October 11, 1 | 1994-10-11 |
Osteogenic proteins Grant 5,266,683 - Oppermann , et al. * November 30, 1 | 1993-11-30 |
Synthetic bioadhesive Grant 5,197,973 - Pang , et al. March 30, 1 | 1993-03-30 |
Thrombus specific conjugates Grant 5,011,686 - Pang April 30, 1 | 1991-04-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.